T1	Participants 86 109	irritability in autism.
T2	Participants 380 453	Participants included 40 outpatient children and adolescents with autism.
T3	Participants 672 710	Eighteen patients in the placebo group
T4	Participants 715 749	16 patients in the buspirone group
T5	Participants 1560 1586	in individuals with autism
